GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ annual meeting.Dr.

Author: Berkeley Lovelace Jr.

This post was originally published on NBC News.